Joustra, V. W. (2023). Pharmaco-epigenetic biomarkers and optimization of post-operative management in inflammatory bowel disease. [Thesis, fully internal, Universiteit van Amsterdam].
Deianova, N. (2023). Health outcome after preterm birth: A microbiota perspective. [Thesis, fully internal, Universiteit van Amsterdam].
Elfiky, A. M. I. M. (2023). Targeted epigenetic therapy in inflammatory bowel disease. [Thesis, fully internal, Universiteit van Amsterdam].
Verburgt, C. M. (2023). Unravelling the microbiome in paediatric Crohn's disease: A journey towards personalised therapy. [Thesis, fully internal, Universiteit van Amsterdam].
Chen, H.-J. (2022). Balancing macrophage activation in health and disease: The epigenetic, transcriptional and immunometabolic insights. [Thesis, fully internal, Universiteit van Amsterdam].
Li Yim, A. Y. F. (2022). Towards the identification of Crohn’s disease-associated epigenetic biomarkers in leukocytes: A potential role in personalized diagnostics and treatment. [Thesis, fully internal, Universiteit van Amsterdam].
Rahman, S. (2022). Cross-talk between microbiota and immune responses in inflammatory bowel disease. [Thesis, fully internal, Universiteit van Amsterdam].
de Krijger, M. (2022). Gut-liver interactions in primary sclerosing cholangitis and inflammatory bowel disease. [Thesis, fully internal, Universiteit van Amsterdam].
Ghiboub, M. (2022). Targeting the immune epigenome in Crohn’s disease. [Thesis, fully internal, Universiteit van Amsterdam].
van Thiel, I. A. M. (2022). Fungal feelings: The gut mycobiome in irritable bowel syndrome and inflammatory bowel disease. [Thesis, fully internal, Universiteit van Amsterdam].
